New drug duo tested in fight against advanced liver cancer
Disease control
Ongoing
This study is testing whether a combination of two drugs, pembrolizumab and bavituximab, can help control advanced liver cancer (hepatocellular carcinoma). It is for patients whose cancer cannot be treated with surgery or localized therapies and who have not yet received other dr…
Phase: PHASE2 • Sponsor: David Hsieh • Aim: Disease control
Last updated Mar 11, 2026 14:52 UTC